The aim of this study was to assess the cost-effectiveness of human papillomavirus (HPV) vaccination in addition to the current cervical cancer screening programme in Germany using a dynamic transmission model
Background: The introduction of a quadrivalent human papillomavirus (HPV; types 6, 11, 16, 18) vacci...
BACKGROUND: Introduction of human papillomavirus (HPV) vaccination in settings with the highest burd...
Background Introduction of human papillomavirus (HPV) vaccination in settings with the highest burd...
Background: The aim of this study was to assess the cost-effectiveness of human papillomavirus (H...
Background The aim of this study was to assess the cost-effectiveness of human papillomavirus (HPV)...
Damm O, Horn J, Mikolajczyk RT, et al. Cost-effectiveness of human papillomavirus vaccination in Ger...
BACKGROUND: The aim of this study was to assess the cost-effectiveness of human papillomavirus (HPV)...
BACKGROUND: The aim of this study was to assess the cost-effectiveness of human papillomavirus (HPV)...
Abstract Background The aim of this study was to assess the cost-effectiveness of human papillomavir...
Introduction Persistent infections with human papillomavirus (HPV) are a necessary cause of cervi...
Aim: Clinical trials have demonstrated the efficacy of the tetravalent human papillomavirus (HPV) va...
Aim: Clinical trials have demonstrated the efficacy of the tetravalent human papillomavirus (HPV) va...
The aim of this study was to assess the cost-effectiveness of human papillomavirus (HPV) vaccination...
Background: Introduction of human papillomavirus (HPV) vaccination in settings with the highest burd...
Background: The introduction of a quadrivalent human papillomavirus (HPV; types 6, 11, 16, 18) vacci...
Background: The introduction of a quadrivalent human papillomavirus (HPV; types 6, 11, 16, 18) vacci...
BACKGROUND: Introduction of human papillomavirus (HPV) vaccination in settings with the highest burd...
Background Introduction of human papillomavirus (HPV) vaccination in settings with the highest burd...
Background: The aim of this study was to assess the cost-effectiveness of human papillomavirus (H...
Background The aim of this study was to assess the cost-effectiveness of human papillomavirus (HPV)...
Damm O, Horn J, Mikolajczyk RT, et al. Cost-effectiveness of human papillomavirus vaccination in Ger...
BACKGROUND: The aim of this study was to assess the cost-effectiveness of human papillomavirus (HPV)...
BACKGROUND: The aim of this study was to assess the cost-effectiveness of human papillomavirus (HPV)...
Abstract Background The aim of this study was to assess the cost-effectiveness of human papillomavir...
Introduction Persistent infections with human papillomavirus (HPV) are a necessary cause of cervi...
Aim: Clinical trials have demonstrated the efficacy of the tetravalent human papillomavirus (HPV) va...
Aim: Clinical trials have demonstrated the efficacy of the tetravalent human papillomavirus (HPV) va...
The aim of this study was to assess the cost-effectiveness of human papillomavirus (HPV) vaccination...
Background: Introduction of human papillomavirus (HPV) vaccination in settings with the highest burd...
Background: The introduction of a quadrivalent human papillomavirus (HPV; types 6, 11, 16, 18) vacci...
Background: The introduction of a quadrivalent human papillomavirus (HPV; types 6, 11, 16, 18) vacci...
BACKGROUND: Introduction of human papillomavirus (HPV) vaccination in settings with the highest burd...
Background Introduction of human papillomavirus (HPV) vaccination in settings with the highest burd...